Researchers explore stem cell therapy for amyotrophic lateral sclerosis

06/19/2014 | Healio (free registration)

Mayo Clinic researchers will conduct an early-stage clinical trial of the use of stem cells to stop the progression of amyotrophic lateral sclerosis. Autologous modified fat-derived mesenchymal stem cells will be infused through a spinal tap to promote nerve cell survival.

View Full Article in:

Healio (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC